| Type | Title | Date Released | |
|---|---|---|---|
DEFA14A | Form DEFA14A | ||
8-K | Lifecore Biomedical Announces Early Termination of HSR Act Waiting Period for Proposed Merger | ||
10-Q | Form 10-Q | ||
8-K | Lifecore Biomedical Reports Third Quarter 2026 Financial Results and Provides Corporate Update | ||
PREM14A | Form PREM14A | ||
8-K | Special Meeting Set for Merger Approval; Shareholders of Record Date Established for November 4, 2026 Vote | ||
SCHEDULE 13D/A | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (Filed by) | ||
8-K | Lifecore Biomedical Enters into Amendment No. 3 to Contract Manufacturing Agreement with Alcon | ||
SCHEDULE 13D/A | Legion Partners Asset Management, LLC (Filed by) | ||
DEFA14A | Form DEFA14A | ||
8-K | Lifecore Biomedical to be Acquired by Webster Equity Partners for up to $663.7 Million | ||
10-Q | Form 10-Q |